Guidance is needed to mitigate the consequences of analytic errors during antimicrobial susceptibility testing for TB

C. U. Köser; J. Robledo; N. Shubladze; T. Schön; D. L. Dolinger; Max Salfinger

doi:10.5588/ijtld.21.0428

Guidance is needed to mitigate the consequences of analytic errors during antimicrobial susceptibility testing for TB

C. U. Köser
, J. Robledo
, N. Shubladze
, T. Schön
, D. L. Dolinger
, Max Salfinger

Research output: Contribution to scientific journal › Review article › peer-review

13 Scopus citations

Original language	English
Pages (from-to)	791-794
Number of pages	4
Journal	International Journal of Tuberculosis and Lung Disease
Volume	25
Issue number	10
DOIs	https://doi.org/10.5588/ijtld.21.0428
State	Published - 1 Oct 2021

Bibliographical note

Funding Information:
CUK received an observership by the European Society of Clinical Microbiology and Infectious Diseases. JR is funded by Ministerio de Ciencia Tecnología e Innovación, Bogotà, Colombia (No. 221389666216 CT-783-2018). CUK is a research associate at Wolfson College, University of Cambridge, and visiting scientist at the Department of Genetics, University of Cambridge, Cambridge, UK. TS is funded by the Swedish Heart and Lung Foundation, Stockholm, and the Swedish Research Council, Stockholm, Sweden. Conflicts of interest: CUK's consulting work for Becton Dickinson involves a collaboration with Janssen, Beerse, Belgium; and Thermo Fisher Scientific, Waltham, MA, USA. CUK also consults for the Foundation for Innovative New Diagnostics, Geneva, Switzerland; and the TB Alliance, New York, NY, USA. CUK worked as a consultant for QuantuMDx, Newcastle upon Tyne, UK; the Stop TB Partnership, Geneva, Switzerland; the WHO Global TB Programme, Geneva, Switzerland; and the WHO Regional Office for Europe, Copenhagen, Denmark. CUK gave a paid educational talk for Oxford Immunotec, Abingdon, UK. Hain Lifescience covered CUK's travel and accommodation to present at a meeting. CUK is an unpaid advisor to BioVersys, Basel, Switzerland; and GenoScreen, Lille, France. JR gave a paid talk for bioMérieux, Marcy l'Etoile, France, and received funding from BD, Franklin Lakes, NJ, USA. DLD works for PhAST, Cambridge, MA, USA. DLD also provides consulting services for Molbio Diagnostics, Verna, India; Partners in Health, Boston, MA, USA; and Médecins Sans Frontières, Paris, France. DLD worked for QuantuMDx.

Funding Information:
CUK received an observership by the European Society of Clinical Microbiology and Infectious Diseases. JR is funded by Ministerio de Ciencia Tecnología e Innovación, Bogotà, Colombia (No. 221389666216 CT-783-2018). CUK is a research associate at Wolfson College, University of Cambridge, and visiting scientist at the Department of Genetics, University of Cambridge, Cambridge, UK. TS is funded by the Swedish Heart and Lung Foundation, Stockholm, and the Swedish Research Council, Stockholm, Sweden.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Types Minciencias

Artículos de investigación con calidad A1 / Q1

Access to Document

10.5588/ijtld.21.0428

Cite this

@article{72d9f6c2c0094492940745925bad2d19,

title = "Guidance is needed to mitigate the consequences of analytic errors during antimicrobial susceptibility testing for TB",

author = "K{\"o}ser, \{C. U.\} and J. Robledo and N. Shubladze and T. Sch{\"o}n and Dolinger, \{D. L.\} and Max Salfinger",

note = "Funding Information: CUK received an observership by the European Society of Clinical Microbiology and Infectious Diseases. JR is funded by Ministerio de Ciencia Tecnolog{\'i}a e Innovaci{\'o}n, Bogot{\`a}, Colombia (No. 221389666216 CT-783-2018). CUK is a research associate at Wolfson College, University of Cambridge, and visiting scientist at the Department of Genetics, University of Cambridge, Cambridge, UK. TS is funded by the Swedish Heart and Lung Foundation, Stockholm, and the Swedish Research Council, Stockholm, Sweden. Conflicts of interest: CUK's consulting work for Becton Dickinson involves a collaboration with Janssen, Beerse, Belgium; and Thermo Fisher Scientific, Waltham, MA, USA. CUK also consults for the Foundation for Innovative New Diagnostics, Geneva, Switzerland; and the TB Alliance, New York, NY, USA. CUK worked as a consultant for QuantuMDx, Newcastle upon Tyne, UK; the Stop TB Partnership, Geneva, Switzerland; the WHO Global TB Programme, Geneva, Switzerland; and the WHO Regional Office for Europe, Copenhagen, Denmark. CUK gave a paid educational talk for Oxford Immunotec, Abingdon, UK. Hain Lifescience covered CUK's travel and accommodation to present at a meeting. CUK is an unpaid advisor to BioVersys, Basel, Switzerland; and GenoScreen, Lille, France. JR gave a paid talk for bioM{\'e}rieux, Marcy l'Etoile, France, and received funding from BD, Franklin Lakes, NJ, USA. DLD works for PhAST, Cambridge, MA, USA. DLD also provides consulting services for Molbio Diagnostics, Verna, India; Partners in Health, Boston, MA, USA; and M{\'e}decins Sans Fronti{\`e}res, Paris, France. DLD worked for QuantuMDx. Funding Information: CUK received an observership by the European Society of Clinical Microbiology and Infectious Diseases. JR is funded by Ministerio de Ciencia Tecnolog{\'i}a e Innovaci{\'o}n, Bogot{\`a}, Colombia (No. 221389666216 CT-783-2018). CUK is a research associate at Wolfson College, University of Cambridge, and visiting scientist at the Department of Genetics, University of Cambridge, Cambridge, UK. TS is funded by the Swedish Heart and Lung Foundation, Stockholm, and the Swedish Research Council, Stockholm, Sweden.",

year = "2021",

month = oct,

day = "1",

doi = "10.5588/ijtld.21.0428",

language = "Ingl{\'e}s",

volume = "25",

pages = "791--794",

journal = "International Journal of Tuberculosis and Lung Disease",

issn = "1027-3719",

publisher = "International Union Against Tuberculosis and Lung Disease ",

number = "10",

}

TY - JOUR

T1 - Guidance is needed to mitigate the consequences of analytic errors during antimicrobial susceptibility testing for TB

AU - Köser, C. U.

AU - Robledo, J.

AU - Shubladze, N.

AU - Schön, T.

AU - Dolinger, D. L.

AU - Salfinger, Max

N1 - Funding Information: CUK received an observership by the European Society of Clinical Microbiology and Infectious Diseases. JR is funded by Ministerio de Ciencia Tecnología e Innovación, Bogotà, Colombia (No. 221389666216 CT-783-2018). CUK is a research associate at Wolfson College, University of Cambridge, and visiting scientist at the Department of Genetics, University of Cambridge, Cambridge, UK. TS is funded by the Swedish Heart and Lung Foundation, Stockholm, and the Swedish Research Council, Stockholm, Sweden. Conflicts of interest: CUK's consulting work for Becton Dickinson involves a collaboration with Janssen, Beerse, Belgium; and Thermo Fisher Scientific, Waltham, MA, USA. CUK also consults for the Foundation for Innovative New Diagnostics, Geneva, Switzerland; and the TB Alliance, New York, NY, USA. CUK worked as a consultant for QuantuMDx, Newcastle upon Tyne, UK; the Stop TB Partnership, Geneva, Switzerland; the WHO Global TB Programme, Geneva, Switzerland; and the WHO Regional Office for Europe, Copenhagen, Denmark. CUK gave a paid educational talk for Oxford Immunotec, Abingdon, UK. Hain Lifescience covered CUK's travel and accommodation to present at a meeting. CUK is an unpaid advisor to BioVersys, Basel, Switzerland; and GenoScreen, Lille, France. JR gave a paid talk for bioMérieux, Marcy l'Etoile, France, and received funding from BD, Franklin Lakes, NJ, USA. DLD works for PhAST, Cambridge, MA, USA. DLD also provides consulting services for Molbio Diagnostics, Verna, India; Partners in Health, Boston, MA, USA; and Médecins Sans Frontières, Paris, France. DLD worked for QuantuMDx. Funding Information: CUK received an observership by the European Society of Clinical Microbiology and Infectious Diseases. JR is funded by Ministerio de Ciencia Tecnología e Innovación, Bogotà, Colombia (No. 221389666216 CT-783-2018). CUK is a research associate at Wolfson College, University of Cambridge, and visiting scientist at the Department of Genetics, University of Cambridge, Cambridge, UK. TS is funded by the Swedish Heart and Lung Foundation, Stockholm, and the Swedish Research Council, Stockholm, Sweden.

PY - 2021/10/1

Y1 - 2021/10/1

UR - https://www.scopus.com/pages/publications/85117003484

U2 - 10.5588/ijtld.21.0428

DO - 10.5588/ijtld.21.0428

M3 - Artículo de revisión

C2 - 34615575

AN - SCOPUS:85117003484

SN - 1027-3719

VL - 25

SP - 791

EP - 794

JO - International Journal of Tuberculosis and Lung Disease

JF - International Journal of Tuberculosis and Lung Disease

IS - 10

ER -